WilliamFernandoBuitragoMDPhD

PubMed

• 28 citations
  Waist circumference predicts increased complications in rectal cancer surgery.
  Courtney J. Balentine, Celia N. Robinson, Christy R. Marshall, Jonathan A. Wilks, William Buitrago
  Journal of Gastrointestinal Surgery. 2010-09-11
• 13 citations
  Real-time diagnosis of Barrett's esophagus: a prospective, multicenter study comparing confocal laser endomicroscopy with conventional histology for the identification...
  Cory Richardson, Paul D. Colavita, Christy M. Dunst, John Bagnato, Peter Billing
  Surgical Endoscopy. 2019-05-01
• 67 citations
  Sebaceous carcinoma: the great masquerader
  William Buitrago, Aaron K. Joseph
  Dermatologic Therapy. 2008-11-01

Journal Articles

• Multiple Skin-colored Papules on the Flank  
  Buitrago WF, Yang DJ, Coleman NM, Hsu S, J Am Acad Dermatol, 1/1/2010
• Sebaceous Carcinoma: The Great Masquerader Emerging Concepts in Diagnosis and Treatment  
  Buitrago W, Joseph AK, Dermatol Ther, 1/1/2008
• Effects of AT1 Antisense Ologonucleotides on Renal Angiotensin II Receptors, Renal Function, and Blood Pressure in Normotensive Rats  
  Buitrago W, Galli S, Phillips I. Buitrago W, Galli S, Phillips I, Proceedings of the National Conference on Undergraduate Research, 1/1/1998
• Synthesis of a Precursor of an Anti-tumor Marine Alkaloid: Shermilamine B  
  Buitrago W, Lyon M, Jackson Y, National Proceedings of the National Conference on Undergraduate Research, 1/1/1997
• Join now to see all

Books/Book Chapters

• Gene and Cell Therapy: Therapeutic Mechanisms and Strategies 
  Chapter: Cutaneous Gene Transfer: Implications for Cell and Gene Therapy of Skin and Systemic Disorders. 
  Page 889 - 911Buitrago W, Roop DRTaylor and Francis, Boca Raton, FLEdition 3rd,2009
• Gene and Cell Therapy: Therapeutic Mechanisms and Strategies. 
  Chapter: Cutaneous Gene Therapy for Skin and Systemic Disorders. 
  Page 657 - 673Buitrago W and Roop DRMarcel Dekker, Inc., New York, NYEdition 2nd,2003

Abstracts/Posters

• Functional Outcomes of Minimally Invasive Surgery versus Open Surgery for Rectal Cancer.
  Buitrago WF, Michael E. DeBakey Department of Surgery Symposium, Baylor College of Medicine, Houston, TX, 1/1/2013
• A Natural Killer from Within.
  Buitrago WF, Annual Department of Medicine Research Symposium, Baylor College of Medicine, Houston, TX, 1/2/2009
• Corrective Gene Therapy for Epidermolysis Bullosa Simplex in an Inducible Mouse Model.
  Buitrago WF, 68th Annual Meeting of the Society for Investigative Dermatology, Los Angeles, CA, 1/9/2007
• Characterization of Cells with Cancer Stem Cells Properties in Skin Squamous Cell Carcinoma.
  Buitrago WF, 68th Annual Meeting of the Society for Investigative Dermatology, Los Angeles, CA, 1/9/2007
• Characterization of Cells with Cancer Stem Cell Properties in Skin Squamous Cell Carcinoma.
  Murao K, Buitrago W and Roop DR, J Invest Dermatol; 68th Annual Meeting of the Society for Investigative Dermatology, 1/1/2007
• Corrective Gene Therapy for Epidermolysis Bullosa Simplex in an Inducible Mouse Model.
  Buitrago W and Roop DR, J Invest Dermatol; 68th Annual Meeting of the Society for Investigative Dermatology, 1/1/2007
• Corrective Gene Therapy for Epidermolysis Bullosa Simplex in an Inducible Mouse Model.
  Buitrago WF, 29th Annual Department of Molecular and Cellular Biology Graduate Student Symposium, Baylor College of Medicine, Houston, TX, 1/1/2007
• Gene Therapy Approaches for Epidermolysis Bullosa Simplex Using an Inducible Mouse Model.
  Buitrago WF, 28th Annual Department of Molecular & Cellular Biology Graduate Student Symposium, Baylor College of Medicine, Houston, TX, 1/28/2006
• Lentivirus-mediated Gene Therapy for Epidermolysis Bullosa Simplex Using an Inducible Mouse Model.
  Buitrago WF, 21st Annual MD/PhD Student National Conference, Keystone, CO, 1/7/2006
• Gene Therapy Approaches for Epidermolysis Bullosa Simplex Using an Inducible Mouse Model.
  Buitrago WF, 67th Annual Meeting of the Society for Investigating Dermatology, Philadelphia, PA, 1/3/2006
• Gene Therapy Approaches for Epidermolysis Bullosa Simplex Using an Inducible Mouse Model.
  Buitrago W, Roop DR, J Invest Dermatol; 67th Annual Meeting of the Society for Investigative Dermatology, 1/1/2006
• Gene Therapy Approaches for the Treatment of Epidermolysis Bullosa Simplex.
  Buitrago WF, 65th Annual Meeting of the Society for Investigating Dermatology, Providence, RI, 1/29/2004
• Gene Therapy Approaches for the Treatment of Epidermolysis Bullosa Simplex using an Inducible Mouse Model.
  Buitrago WF, Medical Scientist Training Program Scientific Symposium, 1/23/2004
• Ribozyme and siRNA Mediated Inhibition of Mutant Keratin 14.
  Buitrago WF, 16th Annual Graduate Student Research Symposium at the Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, 1/7/2004
• Gene therapy Approaches for Epidermolysis Bullosa Simplex.
  Buitrago W, Terron A, McLean I and Roop DR, J Invest Dermatol; 65th Annual Meeting of the Society for Investigative Dermatology, 1/1/2004
• Gene Therapy Approaches for the Treatment of Epidermolysis Bullosa Simplex Using an Inducible Murine Model.
  Buitrago WF, 15th Annual Graduate Student Research Symposium at the Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX, 1/24/2003
• Testing Gene Therapy Approaches for the Treatment of Epidermolysis Bullosa Simplex using an Inducible Mouse Model.
  Buitrago WF, Medical Scientist Training Program Scientific Symposium, 1/22/2003
• Gene Therapy Approaches for the Treatment of Epidermolysis Bullosa Simplex Using an Inducible Murine Model.
  Buitrago WF, Center for Cell and Gene Therapy Annual Retreat, Baylor College of Medicine, Houston, TX, 2002, 2003, 1/1/2003
• Gene Therapy Approaches for the Treatment of Epidermolysis Bullosa Simplex Using an Inducible Murine Model.
  Buitrago WF, Medical Scientist Training Program Scientific Symposium, 1/23/2002
• Role of Granulocyte-Macrophage Colony Stimulating Factor in Langerhans Cell Histiocytosis.
  Buitrago WF, NMRS Research Symposium; SACNAS National Research Conference, Washington, DC, 1998; New York, NY, 1998, 1/21/1998
• Synthesis of a Precursor of an Anti-tumor marine Alkaloid: Shermilamine B.
  Buitrago WF, NMRS Research Symposium, Miami, FL, 1/13/1996
• Join now to see all

Lectures

• Little Giants: Smaller and Smarter Approaches are Taking Minimally Invasive Surgery to the Next Level. 
  1/16/2016
• Bioprinting and Biofabrication are Coming of Age: The �Next Revolution� in Surgery. 
  Baylor College of Medicine, Houston, TX - 1/1/2015
• Lentivirus-mediated Gene Therapy for Epidermolysis Bullosa Simplex Using an Inducible Mouse Model. 
  Baylor College of Medicine, Houston, TX - 1/22/2006
• Gene Therapy Approaches for the Treatment of Epidermolysis Bullosa Simplex. 
  National Institutes of Health, Bethesda, MD - 1/15/2005
• Testing Gene Therapy Approaches for the Treatment of Epidermolysis Bullosa Simplex using an Inducible Mouse Model. 
  Baylor College of Medicine, Houston, TX, 2005; Baylor College of Medicine, Houston, TX, 2005 - 1/10/2005
• Effects of AT1 Antisense Oligonucleotides on Renal Angiotensin II Receptors Renal Function, and Blood Pressure in Normotensive Rats. 
  Salisbury, MD - 1/23/1998
• Who is Afraid of Multiculturalism: A Road to Democracy. 
  Bouton Rouge, LA - 1/1/1998
• Synthesis of a Precursor of an Anti-tumor marine Alkaloid: Shermilamine B. 
  Austin, TX - 1/24/1997
• Toward Multiculturalism and the Decentering of Identity. 
  1/1/1997
• Join now to see all

Other

• Development of Gene Therapy Approaches for Epidermolysis Bullosa Simplex using an Inducible Mouse Model: Implications for Gene Therapy of Inherited Skin Disorders 
  Buitrago WF
  Baylor College of Medicine, Houston, TX - 1/1/2008